By Sheri Kasprzak
New York, April 3 - Discovery Laboratories, Inc. is gearing up to complete a $30,207,500 direct placement of shares.
A group of institutional investors has agreed to buy 14.05 million shares at $2.15 each.
The shares are being sold under the company's shelf registration.
The offering is set to close Thursday.
Jefferies & Co., Inc. is the bookrunner with Lazard Capital Markets LLC as co-agent.
Based in Warrington, Pa., Discovery develops treatments for respiratory diseases in children, adults and premature infants.
| Issuer: | Discovery Laboratories, Inc.
|
| Issue: | Stock
|
| Amount: | $30,207,500
|
| Shares: | 14.05 million
|
| Price: | $2.15
|
| Warrants: | No
|
| Placement agents: | Jefferies & Co., Inc. (lead); Lazard Capital Markets LLC
|
| Announcement date: | April 3
|
| Settlement date: | April 5
|
| Stock symbol: | Nasdaq: DSCO
|
| Stock price: | $2.32 at close April 2
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
